{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:34:18Z","timestamp":1791095658279,"version":"4.1.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T00:00:00Z","timestamp":1361145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056369","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T23:55:39Z","timestamp":1361231739000},"page":"e56369","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pramanicin Analog Induces Apoptosis in Human Colon Cancer Cells: Critical Roles for Bcl-2, Bim, and p38 MAPK Signaling"],"prefix":"10.1371","volume":"8","author":[{"given":"Cagri","family":"Bodur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kutuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Karsli-Uzunbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayirjan T.","family":"Isimjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huveyda","family":"Basaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1537-1891(02)00314-2","article-title":"Pramanicin, an antifungal agent, raises cytosolic Ca2+ and causes cell death in vascular endothelial cells","volume":"40","author":"CY Kwan","year":"2003","journal-title":"Vascul Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10495-005-1894-z","article-title":"Pramanicin induces apoptosis in Jurkat leukemia cells: a role for JNK, p38 and caspase activation","volume":"10","author":"O Kutuk","year":"2005","journal-title":"Apoptosis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1074\/jbc.271.10.5361","article-title":"Molecular cloning of mitogen-activated protein\/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase","volume":"271","author":"JL Blank","year":"1996","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/sj.onc.1202581","article-title":"Caspases: the proteases of the apoptotic pathway","volume":"17","author":"G Nunez","year":"1998","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"H Kim","year":"2006","journal-title":"Nat Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak","volume":"315","author":"SN Willis","year":"2007","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"T Miyashita","year":"1995","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ncb866","article-title":"BID regulation by p53 contributes to chemosensitivity","volume":"4","author":"JK Sax","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"K Nakano","year":"2001","journal-title":"Mol Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"E Oda","year":"2000","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.onc.1204319","article-title":"DNA microarrays identification of primary and secondary target genes regulated by p53","volume":"20","author":"K Kannan","year":"2001","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/MCB.15.6.3032","article-title":"Wild-type human p53 and a temperature-sensitive mutant induce Fas\/APO-1 expression","volume":"15","author":"LB Owen-Schaub","year":"1995","journal-title":"Mol Cell Biol"},{"key":"ref13","first-page":"1593","article-title":"p53-dependent and -independent regulation of the death receptor KILLER\/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha","volume":"58","author":"MS Sheikh","year":"1998","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2005.03.187","article-title":"Stress-induced p53 runs a transcription-independent death program","volume":"331","author":"S Erster","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1158\/0008-5472.CAN-05-1084","article-title":"Mitochondrially targeted p53 has tumor suppressor activities in vivo","volume":"65","author":"F Talos","year":"2005","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15237","DOI":"10.1074\/jbc.274.21.15237","article-title":"p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor","volume":"274","author":"V Budhram-Mahadeo","year":"1999","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.onc.1204067","article-title":"Negative regulation of bcl-2 expression by p53 in hematopoietic cells","volume":"20","author":"Y Wu","year":"2001","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"F Bunz","year":"1998","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"L Zhang","year":"2000","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1039\/b006007k","article-title":"The biosynthesis of pramanicin in Stagonospora sp ATCC 74235: a modified acyltetramic acid","volume":"1","author":"PHM Harrison","year":"2000","journal-title":"Journal of the Chemical Society-Perkin Transactions"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1254\/jjp.85.234","article-title":"Vasorelaxant effects of pramanicin, an anti-fungal agent: selective action on endothelial cells","volume":"85","author":"CY Kwan","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jphs.92.203","article-title":"The epoxy group of pramanicin is required for the optimal endothelium-dependent relaxation of rat aorta","volume":"92","author":"CY Kwan","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1248\/cpb.43.1081","article-title":"Synthesis of Chiral Pyrrolidine Derivatives from (S)-Pyroglutamic Acid.1. 7-Substituted (2r,5s)-2-Aryl-1-Aza-3-Oxabicyclo[3.3.0]Octan-8-Ones, 7-Substituted (2r,5s)-2-Aryl-1-Aza-3-Oxabicyclo[3.3.0]Oct-6-En-8-Ones and 3-Substituted (S)-5-(Hydroxymethyl)-2-Pyrrolidinones","volume":"43","author":"T Nagasaka","year":"1995","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Christoffers J, Werner T, Unger S, Frey W (2003) Preparation of acyloins by cerium-catalyzed, direct hydroxylation of beta-dicarbonyl compounds with molecular oxygen. European Journal of Organic Chemistry: 425\u2013431.","DOI":"10.1002\/ejoc.200390075"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1093\/emboj\/cdg620","article-title":"Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor","volume":"22","author":"A Rajpal","year":"2003","journal-title":"EMBO J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0378-1119(99)00348-0","article-title":"Molecular cloning and functional analysis of the murine bax gene promoter","volume":"238","author":"E Igata","year":"1999","journal-title":"Gene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/1541-7786.MCR-08-0533","article-title":"NGFI-B nuclear orphan receptor Nurr1 interacts with p53 and suppresses its transcriptional activity","volume":"7","author":"T Zhang","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"24903","DOI":"10.1074\/jbc.M500107200","article-title":"Activation of Nur77 by selected 1,1-Bis(3\u2032-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways","volume":"280","author":"S Chintharlapalli","year":"2005","journal-title":"J Biol Chem"},{"key":"ref29","first-page":"533","article-title":"NR4A1, 2, 3\u2013an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis","volume":"21","author":"QX Li","year":"2006","journal-title":"Histol Histopathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2004-07-2752","article-title":"EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX","volume":"105","author":"T Grimm","year":"2005","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","article-title":"Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines","volume":"20","author":"M Bentires-Alj","year":"2001","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2002.00880.x","article-title":"NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis","volume":"81","author":"Y Shou","year":"2002","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/cdd.2008.137","article-title":"Bcl-2 inhibitors: small molecules with a big impact on cancer therapy","volume":"16","author":"M Vogler","year":"2009","journal-title":"Cell Death Differ"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"T Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/annonc\/mdq050","article-title":"Docetaxel-based combination therapy for castration-resistant prostate cancer","volume":"21","author":"MD Galsky","year":"2010","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/jm1001265","article-title":"BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma\/leukemia-2 (Bcl-2) family proteins","volume":"53","author":"J Wei","year":"2010","journal-title":"J Med Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp900150g","article-title":"Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes","volume":"6","author":"W Weecharangsan","year":"2009","journal-title":"Mol Pharm"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1158\/1078-0432.CCR-08-1104","article-title":"Phase I\/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer","volume":"14","author":"SL Moulder","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/JTO.0b013e3181e8f4dc","article-title":"Phase I\/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer","volume":"5","author":"RS Heist","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00280-010-1265-5","article-title":"A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies","volume":"66","author":"PK Paik","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"WH Wilson","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2009.48","article-title":"Different forms of cell death induced by putative BCL2 inhibitors","volume":"16","author":"M Vogler","year":"2009","journal-title":"Cell Death Differ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14728214.2010.515210","article-title":"Emerging Bcl-2 inhibitors for the treatment of cancer","volume":"16","author":"AS Azmi","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/092986712800099839","article-title":"Bcl-2 inhibitors: emerging drugs in cancer therapy","volume":"19","author":"C Bodur","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/jnci\/89.20.1537","article-title":"Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance","volume":"89","author":"MM de las Alas","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"L Chen","year":"2005","journal-title":"Mol Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","article-title":"Bim: a novel member of the Bcl-2 family that promotes apoptosis","volume":"17","author":"L O\u2019Connor","year":"1998","journal-title":"EMBO J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"H Puthalakath","year":"1999","journal-title":"Mol Cell"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1073\/pnas.0438011100","article-title":"JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis","volume":"100","author":"K Lei","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1523\/JNEUROSCI.0233-09.2009","article-title":"A retrograde neuronal survival response: target-derived neurotrophins regulate MEF2D and bcl-w","volume":"29","author":"MF Pazyra-Murphy","year":"2009","journal-title":"J Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/eji.201142226","article-title":"Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells","volume":"42","author":"SF Andrews","year":"2012","journal-title":"Eur J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1158\/0008-5472.CAN-10-1992","article-title":"Inactivation of the orphan nuclear receptor TR3\/Nur77 inhibits pancreatic cancer cell and tumor growth","volume":"70","author":"SO Lee","year":"2010","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/002215540305101204","article-title":"Identification of c-Jun as bcl-2 transcription factor in human uterine endometrium","volume":"51","author":"ZL Li","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"16207","DOI":"10.1074\/jbc.M600539200","article-title":"Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2","volume":"281","author":"N Wajapeyee","year":"2006","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"32099","DOI":"10.1074\/jbc.274.45.32099","article-title":"Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells","volume":"274","author":"L Dong","year":"1999","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.25.5.1608-1619.2005","article-title":"Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas","volume":"25","author":"H Duan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-065X.1994.tb00895.x","article-title":"Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals","volume":"142","author":"DR Green","year":"1994","journal-title":"Immunol Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.V92.3.1003","article-title":"Distinct apoptotic responses imparted by c-myc and max","volume":"92","author":"CE Nesbit","year":"1998","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"39632","DOI":"10.1074\/jbc.M111.253591","article-title":"Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation","volume":"286","author":"J Barthson","year":"2011","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/sj.onc.1205483","article-title":"NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells","volume":"21","author":"CA Heckman","year":"2002","journal-title":"Oncogene"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","article-title":"BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M","volume":"19","author":"K Yamamoto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1002\/jcp.24057","article-title":"Inactivation of Bcl-2 through IkappaB kinase (IKK)-dependent phosphorylation mediates apoptosis upon exposure to 4-hydroxynonenal (HNE)","volume":"227","author":"C Bodur","year":"2012","journal-title":"J Cell Physiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"M Schwickart","year":"2010","journal-title":"Nature"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/emm.2007.27","article-title":"Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression","volume":"39","author":"EJ Lim","year":"2007","journal-title":"Exp Mol Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1536\/ihj.49.329","article-title":"Prostaglandin F2alpha inhibits SERCA2 gene transcription through an induction of Egr-1 in cultured neonatal rat cardiac myocytes","volume":"49","author":"S Hara","year":"2008","journal-title":"Int Heart J"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4161\/cc.7.13.6073","article-title":"Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells","volume":"7","author":"I Vitale","year":"2008","journal-title":"Cell Cycle"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1749-6632.2002.tb03077.x","article-title":"p38 MAP kinase regulation of AP-2 binding in TGF-beta1-stimulated chondrogenesis of human trabecular bone-derived cells","volume":"961","author":"R Tuli","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.144.2.281","article-title":"Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner","volume":"144","author":"EA Slee","year":"1999","journal-title":"J Cell Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0955-0674(00)00216-7","article-title":"Regulation and function of the p53 tumor suppressor protein","volume":"13","author":"KM Ryan","year":"2001","journal-title":"Curr Opin Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T12:53:34Z","timestamp":1595422414000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056369"}},"subtitle":[],"editor":[{"given":"Jose","family":"Vina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,18]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056369","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,18]]}}}